Skip to main content

Table 2 IC50 values of tested compounds ± standard deviation against HepG-2

From: Design, efficient synthesis and molecular docking of some novel thiazolyl-pyrazole derivatives as anticancer agents

Compound No.

IC50 (μg/mL)

Compound No.

IC50 (μg/mL)

Doxorubicin

3.07 ± 0.27

10a

2.20 ± 0.13

3a

4.39 ± 0.47

15a

12.5 ± 0.97

6d

3.90 ± 0.41

21

4.80 ± 0.56

Back to article page

BMC Chemistry

ISSN: 2661-801X

Contact us